BioCentury
ARTICLE | Company News

OncoVista, TATAA Molecular Diagnostics deal

February 1, 2010 8:00 AM UTC

OncoVista's AdnaGen AG subsidiary granted TATAA exclusive rights to use its AdnaTest BreastCancer assay in the COHERTA project. The diagnostic uses RT-PCR to detect biomarkers in circulating tumor c...